Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer January 12, 2021
Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol January 12, 2021
Adagene Announces Milestone of CAR-T Collaboration with the National Heart, Lung, and Blood Institute at the National Institutes of Health January 12, 2021
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling January 11, 2021
Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene Therapy and Expansion of its Clinical Applications January 11, 2021
Beam Therapeutics Appoints Leading Healthcare Executive Kate Walsh to its Board of Directors January 11, 2021